SCHEMBL3852053

SCHEMBL3852053

Cc1n[nH]cc1-c1ccc2nccc(-c3ccc(=O)[nH]c3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 9/20 0.44
AURKA O14965 1/20 0.39
TTK P33981 1/20 0.39
AURKB Q96GD4 1/20 0.39
INCENP Q9NQS7 1/20 0.39
DYRK1B Q9Y463 1/20 0.38
PIK3CA P42336 2/20 0.38
MAP3K14 Q99558 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
CCNK O75909 1/20 0.36
CDK12 Q9NYV4 1/20 0.36
ATM Q13315 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PRKCI P41743 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848395 0.83 ACVR1 (0.42) ACVR1AURKATTKAURKBINCENP
SCHEMBL3859370 0.82 ACVR1 (0.44) ACVR1AURKATTKAURKBINCENP
SCHEMBL3850885 0.81 TLR8 (0.46) ACVR1DYRK1BPIK3CAMAP3K14
Hydrochloric Acid SCHEMBL3846129 0.77 TDO2 (0.42) ACVR1PIK3CAMAP3K14
Hydrochloric Acid SCHEMBL3846888 0.76 ACVR1 (0.41) ACVR1DYRK1BPIK3CAMAP3K14PRKCI
SCHEMBL22119754 0.76 LMNA (0.53) ACVR1DYRK1B
Hydrochloric Acid SCHEMBL3852127 0.75 CA12 (0.42) ACVR1DYRK1BPIK3CAMAP3K14
SCHEMBL10962545 0.74 AURKA (0.62) ACVR1AURKATTKAURKBINCENP
SCHEMBL6637162 0.70 NCF1 (0.45) ACVR1DYRK1BPIK3CA
SCHEMBL3851448 0.70 NCF1 (0.45) ACVR1DYRK1BCCNKCDK12MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed